biotech · Recurrent Pericarditis · Acute Myocarditis · CRDL
Cardiol Therapeutics
Cardiol Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
2265 Upper Middle Rd E, Suite 602, Greater Toronto Area, Ontario L6H 0G5, CA HQ
2017 Founded
27 Employees
Public company Type
CRDL · NYSE Ticker
Company details
- Status
- Public
- HQ
- 2265 Upper Middle Rd E, Suite 602, Greater Toronto Area, Ontario L6H 0G5, CA
- Founded
- 2017
- Employees
- 27
- Programs
- 11
- Drugs
- 31
- Patents
- 15
Cardiol Therapeutics projects
0 ClinicalTrials.gov programs sponsored by Cardiol Therapeutics.
Cardiol Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Cardiol Therapeutics have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.